REPATHA
Solution for injection in pre-filled pen, 140mg
RxActive license
Active substance (INN)
evolocumab
Pharmaceutical form
Pharmaceutical formSolution for injection in pre-filled pen
Strength140mg
PackagingUkupno 2 napunjena injekciona pena sa po 1ml rastvora za injekciju u kartonskoj kutiji
ManufacturerAmgen Europe B.V., Netherlands
Therapeutic groupCardiovascular system (C10AX13)
Marketing authorization holderAMICUS PHARMA DOO PODGORICA
Authorization dateMay 8, 2025
Source: CInMED register